KEY POSITION STATEMENTS
Living Organ Donation Position
Living donation saves lives and often provides the very best possible outcome for the recipient. However, there are several issues that need to be addressed to ensure appropriate protection for these donors.
Immunosuppressive Drug Coverage
Organ transplant recipients must take immunosuppressive medications for the lifetime of their transplanted organ. However, Medicare only covers these essential drugs for 36 months after the transplant.
The success of clinical transplantation in saving the lives of individuals with life-threatening diseases is due to advances made through basic scientific research in the fields of immunology, molecular biology, biochemistry, genetics, and cell biology. NIH-funded research has been the foundation for the development of an infrastructure supporting studies that serve to improve therapy and outcome of patients requiring organ transplants.
Dialysis PATIENTS Demonstration Act
The Dialysis PATIENTS Demonstration Act seeks to promote innovation, efficiency and the improvement of the quality of care for patients receiving kidney dialysis. However, as introduced and pending before the 115th Congress, the Dialysis PATIENTS Demonstration Act is poised to significantly compromise patient access and referral to organ transplantation.